Charles River Laboratories International (CRL) Capital Expenditures Growth (1y) (2010 - 2025)
Charles River Laboratories International (CRL) Capital Expenditures Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 53.06% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 8.47% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -27.73% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -33.33% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 31.13% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 1.48% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 33.33% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 16.40% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 27.78% |
| 10 | Charles River Laboratories International | 12.89 Bn | 12.68 Bn | 1.81 Bn | 17.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | 17.63% |
| Sep 27, 2025 | -8.11% |
| Jun 28, 2025 | -10.61% |
| Mar 29, 2025 | -25.04% |
| Dec 28, 2024 | -3.46% |
| Sep 28, 2024 | -41.28% |
| Jun 29, 2024 | -41.40% |
| Mar 30, 2024 | -25.95% |
| Dec 30, 2023 | -12.02% |
| Sep 30, 2023 | -8.90% |
| Jul 1, 2023 | -18.67% |
| Apr 1, 2023 | 32.82% |
| Dec 31, 2022 | -9.87% |
| Sep 24, 2022 | 30.35% |
| Jun 25, 2022 | 78.44% |
| Mar 26, 2022 | 187.06% |
| Dec 25, 2021 | 286.04% |
| Sep 25, 2021 | 112.09% |
| Jun 26, 2021 | 73.25% |
| Mar 27, 2021 | 8.98% |